Elizabeth K. Lee MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer (NCT05296512) | Elizabeth K. Lee MD | 2022-09-23 |
Track Elizabeth K. Lee MD automatically
Every clearance here is in the API, with alerts when new ones post.